{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:11Z","timestamp":1792784111765,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["R01NS051245"],"award-info":[{"award-number":["R01NS051245"]}]},{"name":"NIH","award":["R01AI056152"],"award-info":[{"award-number":["R01AI056152"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jneuroim.2010.10.018","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T04:26:33Z","timestamp":1291523193000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis"],"prefix":"10.1016","volume":"232","author":[{"given":"Lindsey D.","family":"Jager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rea","family":"Dabelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian W.","family":"Waiboci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulbul M.I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.10.018_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2009.07.007","article-title":"Encephalitogenic T cells that stably express both T-bet and ROR\u03b3t consistently produce IFN\u03b3 but have a spectrum of IL-17 profiles","volume":"215","author":"Abromson-Leeman","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0015","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/JVI.01138-08","article-title":"SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system","volume":"83","author":"Ahmed","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jmb.2009.01.024","article-title":"The SOCS box encodes a hierarchy of affinities for cullin5: implications for ubiquitin ligase formation and cytokine signaling suppression","volume":"387","author":"Babon","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0030","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/glia.21051","article-title":"Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity","volume":"58","author":"Berard","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00714.x","article-title":"From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited","volume":"226","author":"Boniface","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni1551","article-title":"Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system","volume":"9","author":"Cayrol","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signaling pathway","volume":"19","author":"Croker","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imbio.2007.10.008","article-title":"Regulation of innate immunity by suppressor of cytokine signaling proteins","volume":"213","author":"Dalpke","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.1162191","article-title":"Intracellular delivery of a cell-penetrating SOCS1 that targets IFN\u03b3 signaling","volume":"2","author":"DiGiandomenico","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2004.07.017","article-title":"New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"96","author":"El Behi","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-009-9188-9","article-title":"Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"El Behi","year":"2010","journal-title":"J. Neuroimmune Pharmacol"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0070","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.176.6.3293","article-title":"Mechanisms of immunopathology in murine models of central nervous system demyelinating disease","volume":"176","author":"Ercolini","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0075","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni.1775","article-title":"Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE","volume":"10","author":"Farez","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0085","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1074\/jbc.M109.095216","article-title":"Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3","volume":"285","author":"Fletcher","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0090","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.4049\/jimmunol.172.12.7510","article-title":"Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function","volume":"172","author":"Flowers","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0095","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/sj.onc.1208437","article-title":"A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells","volume":"24","author":"Flowers","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2005.08.011","article-title":"Therapeutic role of beta-interferons in multiple sclerosis","volume":"110","author":"Javed","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm1269","article-title":"Intracellular therapy with SOCS3 inhibits inflammation and apoptosis","volume":"11","author":"Jo","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon\u03b3-expressing Th17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni0206-123","article-title":"Mal-function of TLRs by SOCS","volume":"7","author":"Kobayashi","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/2040-7378-1-5","article-title":"Models of autoimmune demyelination in the central nervous system: on the way to translational medicine","author":"Linker","year":"2009","journal-title":"Exp. Transl. Stroke Med"},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ni1299","article-title":"Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation","volume":"7","author":"Mansell","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.autrev.2009.01.006","article-title":"Regulation of autoimmune encephalomyelitis by toll-like receptors","volume":"8","author":"Marta","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin-23 receptor is essential for the terminal differentiation of interleukin-17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0155","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.175.8.5077","volume":"175","author":"Mujtaba","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0160","doi-asserted-by":"crossref","first-page":"iii87","DOI":"10.1136\/ard.2007.078527","article-title":"Interplay between pathogenic Th17 and regulatory T cells","volume":"66","author":"Oukka","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0165","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.4049\/jimmunol.181.5.3167","article-title":"Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes","volume":"181","author":"Qin","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0170","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0022-510X(09)71298-5","article-title":"Knowns and unknowns in the future of multiple sclerosis treatment","volume":"287","author":"Stuve","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0175","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1006\/bbrc.1994.2375","article-title":"The C-terminus of IFN\u03b3 is sufficient for intracellular function","volume":"203","author":"Szente","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0180","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1349-7006.2008.00850.x","article-title":"Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells","volume":"99","author":"Takahashi","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0185","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.4049\/jimmunol.180.6.3746","article-title":"Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN\u03b3 on STAT3 and Smads","volume":"180","author":"Tanaka","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0190","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1021\/jm991025f","article-title":"IFN\u03b3-derived lipopeptide: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells","volume":"42","author":"Thiam","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0195","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.4049\/jimmunol.178.8.5058","article-title":"Both the suppressor of cytokine signaling-1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist","volume":"178","author":"Waiboci","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"Yasukawa","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.jneuroim.2010.10.018_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signaling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:16:33Z","timestamp":1759047393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810004686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0165572810004686"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}